Proteolysis‐targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome‐mediated delivery for targeted protein degradation and therapeutic advancements

Documenti analoghi

• Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy
  di: Zohreh Jahanafrooz, et al.
  Pubblicazione: (2024)
• A review of natural products and small‐molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challenges
  di: Ardalan Pasdaran, et al.
  Pubblicazione: (2024)
• Trifolirhizin targets PTK6 to induce autophagy and exerts antitumor effects in nasopharyngeal carcinoma
  di: Yong Wang, et al.
  Pubblicazione: (2024)
• Starch‐based “smart” nanomicelles: Potential delivery systems for doxorubicin
  di: Parteek Prasher, et al.
  Pubblicazione: (2024)
• Next‐Generation Proteolysis‐Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation
  di: Mohamed S. Nafie, et al.
  Pubblicazione: (2025)